Shares shifted sharply higher as ARM Holdings' Argentine-listed CEDEAR (ARM.BA) jumped 8.5% to $22,840, mirroring a multi-week rally in the underlying Nasdaq-listed stock that has made ARM the best-performing major AI name of 2026. ARM is now up 232% year-to-date, the strongest performer among major AI stocks this year. The question investors must answer: does the company's pivot from quiet chip licensor to AI silicon seller justify what may be the richest valuation in semiconductors?
Wall Street Is Tripping Over Itself to Raise Targets
Wells Fargo hiked its price target to $410; Mizuho went to $500, projecting up to $15 billion in AI CPU infrastructure revenue by fiscal 2031.
Bank of America raised to $335 but kept a Neutral rating, giving investors a reason to reprice but also flagging caution. The sheer volume of upgrades creates buying pressure, but it also means the good news is rapidly getting priced in.
The Big Bet: Selling Chips, Not Just Blueprints
In March 2026, ARM announced a 136-core data center processor co-developed with Meta — the first production silicon in the company's 35-year history.
The company has secured more than $2 billion in customer commitments for fiscal 2027 and 2028, targeting up to $15 billion in annual AI CPU revenue by 2031. That's transformational — but it also puts ARM in direct competition with customers like Nvidia and Qualcomm who license its designs.
The FTC Cloud Hanging Over the Pivot
The FTC opened a formal antitrust investigation examining whether ARM intends to degrade or deny licenses to companies like Apple, Qualcomm, and Nvidia while selling its own competing chips.
Similar probes are underway in Europe and South Korea. Any restrictions on ARM's ability to both license designs and sell chips could fundamentally undermine the growth story investors are paying up for.
The Valuation Leaves Zero Room for Error
At roughly 183 times earnings and 24 times sales, the stock embeds aggressive AI growth assumptions.
Q4 fiscal 2026 revenue of $1.49 billion and adjusted earnings of $0.60 per share were strong, but AGI CPU demand is currently limited by wafer, memory, and packaging capacity.
Meanwhile, insiders sold $24.6 million in shares over the past three months — not the kind of signal that matches the stock's euphoric tone. ARM's AI ambition is real, but at this price, execution must be flawless.